Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PLSE - Pulse Biosciences, Inc.

IEX Last Trade
18.09
-0.260   -1.437%

Share volume: 134
Last Updated: Thu 26 Dec 2024 04:29:30 PM CET
Surgical and Medical Instrument Manufacturing : 1.37%

PREVIOUS CLOSE
CHG
CHG%
$18.35
-0.26
-1.42%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
27%
Profitability 43%
Dept financing 24%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.95%
1 Month
1.92%
3 Months
8.27%
6 Months
82.93%
1 Year
44.79%
2 Year
624.51%
Key data
Stock price
$18.09
P/E Ratio 
-28.94
DAY RANGE
$17.99 - $18.42
EPS 
-$0.91
52 WEEK RANGE
$6.78 - $22.69
52 WEEK CHANGE
$42.76
MARKET CAP 
1.142 B
YIELD 
N/A
SHARES OUTSTANDING 
61.290 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
2.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$169,176
AVERAGE 30 VOLUME 
$180,877
Company detail
CEO: Kevin Danahy
Region: US
Website: pulsebiosciences.com
Employees: 140
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue.

Recent news